Backed By $11 Million Investment, Biofrontera Restructures Relationship With Biofrontera AG
Biofrontera Inc. has acquired all U.S. Rights to Ameluz and RhodoLED from its former parent company, Germany-based Biofrontera AG.
Day: June 30, 2025
Biofrontera Inc. has acquired all U.S. Rights to Ameluz and RhodoLED from its former parent company, Germany-based Biofrontera AG.